Have a Claim?

Click here for a confidential contact or call:


April 6, 2020

Posted  April 6, 2020

Georgia-based MiMedx Group Inc. has agreed to pay $6.5 million to settle allegations of defrauding the Department of Veterans’ Affairs by knowingly submitting false commercial pricing disclosures, in violation of the False Claims Act.  According to a qui tam complaint by whistleblowers Jess Kruchoski and Luke Tornquist, the false pricing disclosures enabled MiMedx to charge inflated prices for human tissue graft products.  Kruchoski and Tornquist will receive a relator’s share of $1,625,000.  DOJ; USAO MN

Tagged in: Drug and DME Pricing, FCA Federal, Government Procurement Fraud, Healthcare Fraud, Medical Billing Fraud, Whistleblower Case, Whistleblower Rewards,